Show
Sort by
-
Remote HbA1c testing via microsampling : fit for purpose?
-
- Journal Article
- A1
- open access
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients : a prospective single center observational study
-
- Journal Article
- A1
- open access
Therapeutic drug monitoring of tyrosine kinase inhibitors using dried blood microsamples
-
Suboptimal beta-lactam therapy in critically ill children : risk factors and outcome
-
- Journal Article
- A1
- open access
Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
-
Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit
-
Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces
-
Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method
-
Corrigendum to 'Early target attainment of continuous infusionpiperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study' [Journal of Critical Care 52(2019) 75–79]
-
Prolonged versus intermittent infusion of β-lactam antibiotics : a systematic review and meta-regression of bacterial killing in preclinical infection models
-
Comment on HbA(1c) determination from HemaSpot blood collection devices : comparison of home-prepared dried blood spots with standard venous blood analysis
-
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem : a comparison of eight pharmacokinetic models
-
Evaluation of three different lipase reagents on the Abbott Alinity C chemistry analyzer
-
Measuring antibiotics in exhaled air in critically ill, non-ventilated patients : a feasibility and proof of concept study
-
Subtherapeutic piperacillin concentrations in neurocritical patients
-
Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study
-
Persistence of piperacillin concentrations after treatment discontinuation : in cauda venenum?
-
Measuring unbound versus total piperacillin concentrations in plasma of critically ill patients : methodological issues and relevance
-
Amoxicillin/clavulanic acid dosing in frail geriatric patients : do we need a tailored dosing regimen?
-
Saturable elimination of piperacillin in critically ill patients : implications for continuous infusion